Andreadis C, Bobek O, Hsi ED, Fenske TS, et al. Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup doub Leuk Lymphoma 2025 Jul 9:1-10. doi: 10.1080/10428194.2025.2525982.
PMID: 40632607